Why Growing Health Brands Struggle With International Expansion
CONTRIBUTED POST
For many health and wellness brands, international expansion seems like the natural next step after achieving success in their home market.
Demand for health products continues to grow worldwide, creating attractive opportunities for companies looking to reach new customers and increase revenue.
However, expanding across borders is rarely as straightforward as it appears.
Different countries have unique regulations, product registration requirements, labeling standards, import restrictions, and consumer expectations that can quickly complicate growth plans.
What works in one market may not translate easily to another. Without careful planning and the right operational support, expansion efforts can stall.
Below are some of the most common challenges growing health brands face and what successful global companies do differently to overcome them.
1. Regulatory Approval Timelines Are Brutal
Health and wellness products face a level of regulatory scrutiny that consumer goods brands in other categories simply don't encounter.
Supplements, functional foods, medical devices, and personal care products all fall under different regulatory frameworks in different countries — and many require pre-market approval or registration before a single unit can be sold.
The EU, Canada, Australia, Japan, and Brazil each have their own approval bodies, ingredient restrictions, and labeling requirements.
What's fully legal and compliant in the U.S. may require reformulation, new documentation, or a 12-month registration process in another market.
Brands that don't map this landscape before committing to a launch timeline almost always find themselves behind schedule and over budget.
2. Labeling Compliance Counts
Labeling compliance is one of the most underestimated challenges in international health product expansion.
It's not just about translation. It's about meeting country-specific requirements for ingredient disclosure, allergen statements, health claims, net quantity declarations, and mandatory warnings — each regulated differently by each jurisdiction.
Health claims that are permitted in one market may be restricted or outright prohibited in another.
Running afoul of labeling regulations can result in shipments being held at customs, product recalls, or mandatory relabeling at destination — all of which are expensive and operationally disruptive.
3. Supply Chain Complexity Multiplies Quickly
Health brands often source ingredients from multiple countries, manufacture in others, and sell in still others. That web of movement creates significant cross-border compliance obligations — import duties, export licensing in some cases, certificates of origin, and phytosanitary or health certificates depending on the product category.
Managing that complexity without dedicated cross-border expertise is genuinely difficult. That's where working with Livingston International helps health brands move goods across borders with the right documentation, proper classification, and the regulatory knowledge to avoid the clearance failures that derail international launches.
4. Currency and Payment Infrastructure
Even when the product clears customs successfully, health brands often find that international revenue is harder to collect than expected.
Currency fluctuations affect margin. International payment processing requires different infrastructure than domestic operations. And in some markets, preferred payment methods are entirely different from what the brand has built around.
These aren't insurmountable problems, but they require advance planning.
Brands that treat payment infrastructure as an afterthought consistently find it slowing down their first months of operation in a new market.
5. E-Commerce Platforms Don't Always Translate
A brand's domestic e-commerce stack — built around U.S. fulfillment, U.S. shipping carriers, and U.S. payment processors — typically doesn't serve international customers well out of the box.
Duties and taxes at checkout, international shipping rates, delivery time estimates, and returns logistics all need to be rebuilt for each market.
According to a report by the International Trade Centre, small and medium-sized health product exporters cite logistical complexity as the number one barrier to international e-commerce growth.
Getting the customer-facing experience right is inseparable from getting the operational backend right.
6. Distributor Relationships Require Vetting
Many health brands enter international markets through local distributors — a sensible approach, but one that introduces its own risks.
Distributor quality varies enormously. A poor distributor relationship can result in inconsistent brand presentation, compliance shortcuts, or simply low sales effort in a market where the brand has limited visibility.
The vetting process for international distribution partners should be as rigorous as hiring a senior employee.
Reference checks, regulatory compliance track record, and clear contractual obligations around brand standards all matter more than they might seem upfront.
Conclusion
The health brands that scale internationally successfully share a common trait: they treat operational and regulatory infrastructure as part of the product launch, not a separate workstream that gets figured out later.
Every challenge listed above is manageable with the right preparation. Discovered mid-launch, each one is a crisis.
Start with the markets where your regulatory pathway is clearest.
Build compliance infrastructure before you need it at volume. And invest in cross-border operational expertise early — it pays for itself faster than most brands expect.